Owner Array BioPharma, Inc. Astrazeneca AB

Inventors Marlow, Allison L.; Wallace, Eli; Seo, Jeongbeob; Lyssikatos, Joseph P.; Yang, Hong Woon; Blake, Jim; Storey, Richard Anthony; Booth, Rebecca Jane; Pittam, John David; Leonard, John; Fielding, Mark Richard

Agent Watermark

Pub. Number AU-A-2012211395

Parent 2006299902

Filing date 8 August 2012

Wipo publication date 30 August 2012

C07D 211/74 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4412 - having oxo groups directly attached to the heterocyclic ring

A61K 31/50 - Pyridazines

C07D 211/86 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/63 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/70 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 237/12 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 237/14 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings